MERCK: otro más que sale de compras...

Clark said "strategic opportunities," including possible acquisitions, would be a key priority for 2009. He reiterated his interest in acquiring a biotech company that would boost Merck's revenue as well as its pipeline of experimental drugs.

Mas...